Fetal RHD Screening is publicly funded for Ontario residents who:
- Are RhD negative
- Do not have anti-D antibodies
- Are pregnant with one baby
This website uses cookies to enhance usability and provide you with a more personal experience. By using this website, you agree to our use of cookies as explained in our Privacy Policy.
Fetal RHD Screening is a non-invasive test that predicts the RhD blood type of a fetus using cell-free DNA from a pregnant person's blood as early as 11 weeks' gestation. This publicly funded test is designed to guide RhD Immune Globulin (RhIG) treatment in pregnancies at risk of RhD alloimmunization.
Who is Fetal RHD Screening for?
Fetal RHD Screening is publicly funded for Ontario residents who:
When is Fetal RHD Screening done?
How does Fetal RHD Screening work?
· This test uses a sample of your blood. During pregnancy, small pieces of genetic material from the placenta circulate in your blood. The lab looks at this material to predict your baby’s RhD blood type.
How to get Fetal RHD Screening?
How long does it take to get results?
Contact Us
Prenatal Screening Ontario
CHEO Research Institute
Centre for Practice-Changing Research Building
401 Smyth Road
Ottawa, ON K1H 8L1
Information line
Phone: 613-737-2281
Toll-Free: 1-833-351-6490
Monday to Friday, 9:00 AM to 3:00 PM EST
Subscribe to PSO Updates
Subscribe to stay informed about the latest PSO news and prenatal screening updates in Ontario.
Virtual educational sessions on prenatal screening and nuchal translucency quality assurance are available upon request for health‑care providers.